The HemOnc Pulse
Part Two: The Question of MRD in CLL Therapy
August 22, 2024
In part two of this episode, Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Center;Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center; andAlan Skarbnik, MD, of Novant Health, continue to explore the role of measurable residual disease (M
Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Chadi Nabhan, MD, MBA, FACP, covering all topics in the world of hematologic oncology.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast